Clinical Trial Update: Alendronate Osteoporosis Study [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes completion of phase 2 and phase 3 for alendronate in glucocorticoid-associated osteopenia and osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteopenia
• Glucocorticoid-induced Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Glucocorticoid-Associated Osteopenia and Osteoporosis | Phase 2, Phase 3 | Status: COMPLETED